Recruiting NA Ulnar Collateral Ligament Sprain

New treatment option for Ulnar Collateral Ligament Sprain

Official title Validating the Speckle Tracking Methods on Soft Tissue Strain, Displacement, and Roles in Physical Therapy

ClinicalTrials.gov ID: NCT07485530

What this study is testing

What it's testing
This three-year research project aims to test the hypothesis that strain and displacement characteristics of human soft tissues are influenced by (1) habitual physical activity, (2) functional impairment, and (3) training interventions. Over the three years, the ulnar collateral ligament of the elbow, the ankle tendon, and the hamstring muscles will be investigated sequentially.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 65. Healthy volunteers may be eligible.

You may be able to join if

  • Study 1
  • male pitchers aged between 18 and 35 years
  • more than five years of pitching experience
  • at least 200 counts of pitching training per week Study 2
  • Age between 20 and 65 years

You likely can't join if

  • Study 1
  • diagnosed with partial or full thickness tears of the UCL by arthrographic/ nonarthrographic MR techniques in past medical records
  • having a positive result in the "moving valgus stress test" screening24
  • unable to participate in regular baseball pitching training or absent from the competition during the March 2023 to March 2025 season
  • found to show suspicious signs, such as hypoechoic foci and calcification, which suggest UCL injury under ultrasound screening4
  • with a \<80% compliance rate in the eight-week BFRT Study 2
See the full eligibility criteria
Who can join
  • Study 1
  • male pitchers aged between 18 and 35 years
  • more than five years of pitching experience
  • at least 200 counts of pitching training per week Study 2
  • Age between 20 and 65 years
  • diagnosed with grade II posterior tibial tendon dysfunction and recommended by a physician for surgical intervention Study 3
  • The participants were between 18 and 45 years old
  • had undergone unilateral anterior cruciate ligament semitendinosus tendon autograft reconstruction surgery within the past 6 years
  • were able to fully participate in the sports and training they had before their injury
What rules you out
  • Study 1
  • diagnosed with partial or full thickness tears of the UCL by arthrographic/ nonarthrographic MR techniques in past medical records
  • having a positive result in the "moving valgus stress test" screening24
  • unable to participate in regular baseball pitching training or absent from the competition during the March 2023 to March 2025 season
  • found to show suspicious signs, such as hypoechoic foci and calcification, which suggest UCL injury under ultrasound screening4
  • with a \<80% compliance rate in the eight-week BFRT Study 2
  • The lower extremities have undergone surgical intervention
  • The lower extremities have a known history of nerve or vascular injury
  • The ankles and feet have known ligament tears
  • Fixed deformities of the foot joints
  • The patient has a known physical condition that would affect the conduct of the experiment Study 3
  • Having any orthopedic condition that prevents them from participating in the competition, such as arthritis or knee pain
  • having a history of hamstring muscle strain in the knee within the past 3 months
  • having an attendance rate of less than 80% in the subsequent eight weeks of training

The study team makes the final eligibility decision.

Where it's taking place

  • Taipei, Taiwan

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Taipei, Taiwan. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.